Effectiveness of full mRNA vaccinations to prevent COVID-19 among immunocompromised patients receiving tixagevimab-cilgavimab as pre-exposure prophylaxis-authors' response
J Formos Med Assoc. 2025 Jul 11:S0929-6646(25)00293-1.
doi: 10.1016/j.jfma.2025.06.019.
Online ahead of print.
1 Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
2 Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
3 Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; National Institutes of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan.
4 Department of Internal Medicine, National Taiwan University Cancer Center, Taipei, Taiwan.
5 Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; National Institutes of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan; School of Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
6 Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; School of Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: changsc@ntu.edu.tw.